Advertisement

Topics

Immune repurchases rights to Mylan's leukemia drug Ceplene

05:40 EDT 19 Jun 2017 | SmartBrief

Immune Pharmaceuticals has entered into a contract allowing the firm to reacquire assets for Mylan's Ceplene, or histamine di -More

Original Article: Immune repurchases rights to Mylan's leukemia drug Ceplene

NEXT ARTICLE

More From BioPortfolio on "Immune repurchases rights to Mylan's leukemia drug Ceplene"

Advertisement
Quick Search
Advertisement
Advertisement